siRNA-Mediated RNA Interference in Precision-Cut Tissue Slices Prepared from Mouse Lung and Kidney

Mitchel J R Ruigrok1, Nalinie Maggan1, Delphine Willaert1

  • 1Groningen Research Institute of Pharmacy, Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.

The AAPS Journal
|September 13, 2017
PubMed

Insights

Self-deliverable small interfering RNA (siRNA) effectively silences genes in precision-cut lung and kidney slices (PCLuS/PCKS) ex vivo. This model bridges the gap between cell cultures and animal studies for RNA interference research.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • RNA interference (RNAi) using small interfering RNA (siRNA) is crucial for gene function studies.
  • Existing in vitro and in vivo models present translational challenges.
  • A need exists for experimental models combining in vitro and in vivo advantages.

Purpose of the Study:

  • To evaluate the efficacy of self-deliverable siRNA (Accell siRNA) in precision-cut lung slices (PCLuS) and precision-cut kidney slices (PCKS) for ex vivo RNAi.
  • To assess the impact of Accell siRNA on slice viability and morphology.
  • To investigate siRNA delivery and gene silencing in a relevant organoid model.

Main Methods:

  • Preparation of precision-cut lung slices (PCLuS) and precision-cut kidney slices (PCKS) from mouse tissue.
  • Incubation of slices with no siRNA, non-targeting Accell siRNA, or Gapdh-targeting Accell siRNA for up to 48 hours.
  • Assessment of gene silencing via mRNA levels, cell viability, morphology, and siRNA diffusion using fluorescence microscopy.

Main Results:

  • Significant Gapdh mRNA silencing was achieved in PCLuS (~55%) and PCKS (~40%) without compromising tissue integrity.
  • Accell siRNA demonstrated diffusion into both PCLuS and PCKS.
  • Spontaneous inflammation markers (Il1b, Il6, Tnfa) were observed, with Accell siRNA potentially mitigating this in PCLuS.

Conclusions:

  • Precision-cut tissue slices (PCTS) provide a viable ex vivo model for siRNA-mediated RNAi.
  • This model effectively mimics organ characteristics for studying siRNA effects.
  • Accell siRNA is a promising tool for ex vivo gene silencing in lung and kidney tissues.